192 related articles for article (PubMed ID: 7856502)
21. FDA community meeting May 16: clinical trials and viral load. Food and Drug Administration.
AIDS Treat News; 1997 May; (No 270):3. PubMed ID: 11364324
[TBL] [Abstract][Full Text] [Related]
22. Indian company seeks US approval for generic AIDS drugs.
Nature; 2004 Aug; 430(7001):716. PubMed ID: 15306779
[No Abstract] [Full Text] [Related]
23. Let there be drugs.
Gilden D
GMHC Treat Issues; 1996 Feb; 10(2):1, 13-6. PubMed ID: 11363380
[TBL] [Abstract][Full Text] [Related]
24. IRB/FDA requirements relevant to HIV/AIDS clinical trials in correctional settings.
Cohen J;
AIDS Read; 2001 Jan; 11(1):41-2. PubMed ID: 11215087
[TBL] [Abstract][Full Text] [Related]
25. FDA reform: activists' proposals. Food and Drug Administration.
James JS
AIDS Treat News; 1995 Aug; (no 228):6-8. PubMed ID: 11362628
[TBL] [Abstract][Full Text] [Related]
26. Antiviral AIDS drug nears approval.
Science; 1991 Apr; 252(5003):206-7. PubMed ID: 1901425
[No Abstract] [Full Text] [Related]
27. FDA reiterates personal-use importation policy to buyers' clubs.
Clin Pharm; 1993 Sep; 12(9):636-7. PubMed ID: 8306562
[No Abstract] [Full Text] [Related]
28. Activists now urge caution on approval of new AIDS drug.
MacIlwain C
Nature; 1993 Sep; 365(6445):378. PubMed ID: 8413575
[No Abstract] [Full Text] [Related]
29. New drug approved to treat HIV.
Treat Rev; 1997 Apr; (No 24):5. PubMed ID: 11364284
[TBL] [Abstract][Full Text] [Related]
30. Potent new AIDS drugs underscore promise of combination therapy.
AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
[TBL] [Abstract][Full Text] [Related]
31. Whatever happened to expanded access?
Notes Undergr; 1997; (No 35):2-3. PubMed ID: 11364564
[TBL] [Abstract][Full Text] [Related]
32. Experimental AIDS drug d4T, now available to patients in critical need.
Ann Allergy; 1993 Sep; 71(3):A24. PubMed ID: 8396862
[No Abstract] [Full Text] [Related]
33. FDA panel unanimously recommends approval of Vistide for CMV retinitis. Food and Drug Administration.
J Int Assoc Physicians AIDS Care; 1996 May; 2(5):50. PubMed ID: 11363532
[TBL] [Abstract][Full Text] [Related]
34. FDA workshop on clinical trial design, September 6-7--registration by Aug. 18. Food and Drug Administration.
James JS
AIDS Treat News; 1995 Aug; (no 228):5-6. PubMed ID: 11362627
[TBL] [Abstract][Full Text] [Related]
35. Investigational new drug, antibiotic, and biological product applications; clinical hold and termination--FDA. Final rule.
Fed Regist; 1992 Apr; 57(73):13244-9. PubMed ID: 10118458
[TBL] [Abstract][Full Text] [Related]
36. AIDS treatment. A step toward cheaper anti-HIV therapy.
Cohen J
Science; 2005 Feb; 307(5710):653. PubMed ID: 15692020
[No Abstract] [Full Text] [Related]
37. Generic AZT cleared for use.
AIDS Patient Care STDS; 2005 Nov; 19(11):780. PubMed ID: 16320374
[No Abstract] [Full Text] [Related]
38. AIDS drugs. DDI nears approval.
Aldhous P
Nature; 1991 Jul; 352(6333):269. PubMed ID: 1906581
[No Abstract] [Full Text] [Related]
39. AmFAR extols FDA on rapid approval of two protease inhibitors.
AIDS Patient Care STDS; 1996 Jun; 10(3):193-4. PubMed ID: 11361645
[No Abstract] [Full Text] [Related]
40. Consensus statement on the further development of protease inhibitors and human growth hormone.
AIDS Treat News; 1996 Mar; (no 243):8. PubMed ID: 11363302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
